News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Class Action Lawsuit Accuses BIOLASE Technology, Inc. (BIOL) and Officers of Lying to Investors



8/30/2013 8:10:30 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

A group of Biolase shareholders are suing in a class action lawsuit accusing company directors of lying about its financial struggles. Biolase (NSDQ:BLTI) is facing a lawsuit brought by shareholders accusing the company of hiding problems by lying on quarterly earnings reports. The lawsuit claims Biolase and its directors concealed liquidity and solvency issues as well as under-performing sales. The class action claims that Biolase was lying on earnings reports during the better part of 2013.

Help employers find you! Check out all the jobs and post your resume.

Read at MassDevice
Read at News Release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES